{"filing":{"accession_number":"0001213900-26-077274","cik":"0001560293","ticker":"TNONW","company_name":"Tenon Medical, Inc.","form":"8-K","filing_date":"2026-07-10","report_date":null,"primary_document":"ea0297192-8k_tenon.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026077274/ea0297192-8k_tenon.htm"},"events":[{"id":17417,"run_id":15593,"accession_number":"0001213900-26-077274","anchor_item_number":"8.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"The filing discloses that Nasdaq notified the Company on May 21, 2026, that it was no longer in compliance with the minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market. Although the Company raised $4.2 million in a July 1, 2026 offering and believes it now satisfies the requirement, Nasdaq will continue monitoring compliance, and the Company \"may be subject to delisting\" if it does not evidence compliance by its September 30, 2026 Form 10-Q. This is a classic delisting-risk disclosure under Item 3.01 principles, disclosed here under Item 8.01.","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-07-10","form":"8-K","submitted_at":null,"items":[{"id":15875,"accession_number":"0001213900-26-077274","item_number":"8.01","item_title":"Other Events","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that Nasdaq notified the Company on May 21, 2026, that it was no longer in compliance with the minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market. Although the Company raised $4.2 million in a July 1, 2026 offering and believes it now satisfies the requirement, Nasdaq will continue monitoring compliance, and the Company \"may be subject to delisting\" if it does not evidence compliance by its September 30, 2026 Form 10-Q. This is a classic delisting-risk disclosure under Item 3.01 principles, disclosed here under Item 8.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-11T00:17:38.479748+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":15875,"accession_number":"0001213900-26-077274","item_number":"8.01","item_title":"Other Events","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that Nasdaq notified the Company on May 21, 2026, that it was no longer in compliance with the minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market. Although the Company raised $4.2 million in a July 1, 2026 offering and believes it now satisfies the requirement, Nasdaq will continue monitoring compliance, and the Company \"may be subject to delisting\" if it does not evidence compliance by its September 30, 2026 Form 10-Q. This is a classic delisting-risk disclosure under Item 3.01 principles, disclosed here under Item 8.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-11T00:17:38.479748+00:00","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-07-10"}]}